Acquired Immune Deficiency Syndrome Antiretroviral Therapy

Overview

4.5 out of 5 (114 Reviews)

Credits

1.00

Post Assessment Questions

5

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Human immunodeficiency virus infection is a significant health problem worldwide. Advances in treatment have made this disease not only manageable but have also dramatically decreased the incidence of opportunistic infections and decreased progression to acquired immunodeficiency syndrome. Practitioners should utilize current guidelines for treatment. This activity describes these guidelines and highlights the role of interprofessional teams in treating this complex disorder.

UAN: JA4008338-0000-23-309-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Describe how a patient with acute HIV infection might present, and the initial screening test that should be done.
  • Identify when antiretroviral therapy should be initiated in patients with human immunodeficiency virus.
  • Outline some common antiretroviral therapy regimens.
  • Summarize collaboration with interprofessional team members to ensure that high risk patients are being educated about and offered pre-exposure HIV prophylaxis.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.00 ACPE credit(s). (UAN: JA4008338-0000-23-309-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Deborah Z. on 1/17/2021

OSCAR P. on 5/25/2021

Kelsey G. on 8/5/2021

Harry A. on 10/4/2021

I have an increased knowledge on this topic based on this activity

shelley h. on 11/15/2021

Sunaina R. on 1/20/2022

Ragi R. on 2/4/2022

Alpana S. on 1/19/2023

Russell R. on 2/22/2022

Preeti S. on 3/26/2022

Christine G. on 9/12/2022

Leon C. on 10/8/2022

Good job

Kenneth R. on 10/31/2022

Nicholas G. on 12/15/2022

Shantu P. on 3/11/2023

Adel s. on 4/6/2023

Jess P. on 4/10/2023

Christine G. on 4/16/2023

Very good explanation /teaching of this important topic.

Bernadette M. on 4/21/2023

Anandit M. on 4/21/2023

Laxmi S. on 6/4/2023

Ashley N. on 10/4/2023

Preman S. on 10/5/2023

Raul V. on 10/14/2023

Ralph C. on 10/17/2023

DELALI A. on 10/23/2023

maria j. on 10/25/2023

Ali S. on 11/14/2023

Edward F. on 11/19/2023

GARY T. on 11/21/2023

William L. on 11/30/2023

kristi f. on 11/30/2023

Robert P. on 12/1/2023

makondo s. on 12/5/2023

Kamran T. on 12/14/2023

Aviva Z. on 12/19/2023

mohamad a. on 12/20/2023

sanaz l. on 1/10/2024

Barbara S. on 12/22/2023

Cynthia M. on 12/23/2023

osei b. on 12/25/2023

Jamie J. on 12/27/2023

Christopher B. on 12/30/2023

Andrea C. on 12/30/2023

Ronald F. on 12/30/2023

Tawana T. on 12/31/2023

Guillermo M. on 12/31/2023

Bibek K. on 12/31/2023

David B. on 1/1/2024

Trishala A. on 1/19/2024

Patricia S. on 1/29/2024

Lazo K. on 1/30/2024

John O. on 2/16/2024

Guillermo P. on 2/25/2024

ISLAM A. on 3/3/2024

Bozena B. on 3/3/2024

Olusanya R. on 3/3/2024

Alan S. on 3/9/2024

ROXANNA R. on 2/24/2024

Kelly M. on 3/14/2024

Ricardo Q. on 3/15/2024

PATRICK S. on 2/18/2024

john d. on 2/8/2024

edwin g. on 2/7/2024

Kaman C. on 2/4/2024

hans r. on 1/29/2024

In patients with CKD Elvitegravir-cobicistat/Tenofovir Fumarate/Emtricitabine (CrCl greater than 70), and Elvitegravir-cobicistat/Tenofovir Alafenamide/Emtricitabine (CrCl greater than 30) should be avoided. these are errors; should be <

Gregory A. on 3/31/2024

Sarah G. on 4/3/2024

Colin M. on 1/20/2024

Mary C. on 1/20/2024

Bruce T. on 12/19/2023

cyrus i. on 4/10/2024

None

Michael K. on 11/7/2023

Andrew R. on 4/15/2024

Nancy A. on 4/25/2024

Mohammed J. on 10/28/2023

musib g. on 4/28/2024

Lazo K. on 10/26/2023

ishvar p. on 5/14/2024

larry m. on 3/21/2023

Anwar K. on 5/27/2024

Indumathi D. on 2/22/2023

Aneesh M. on 5/31/2024

James M. on 6/10/2024

Brian C. on 12/31/2022

Arnel L. on 6/30/2024

Joseph B. on 7/2/2024

Ikechukwu A. on 7/4/2024

Noel J. on 10/26/2022

Makeswaran S. on 7/15/2024

Unless I am doing a lot of HIV treatment, memorizing the particular names of medications that helpful. I will need to look them up anyway. Understanding the concepts involved is very important.

Robert V. on 7/23/2022

Dr.NIRMALA M. on 11/4/2022

mv zdfMXB

Scott J. on 4/17/2022

Thanks much

Dr. Mallikarjuna S. on 4/15/2022

Kriti M. on 2/1/2022

Amit G. on 5/9/2021

Arthur C. on 12/6/2020

Patrick C. on 3/11/2024

TRINA S. on 3/3/2024

Elliot S. on 3/24/2024

Nyomi W. on 3/28/2024

Zahid Q. on 3/28/2024

Lisa D. on 3/30/2024

larry m. on 3/30/2024

Aparajtia S. on 4/4/2024

Mohammad G. on 4/4/2024

Fernando M. on 4/9/2024

John B. on 4/14/2024

ANDREW U. on 4/28/2024

michael a. on 4/29/2024

William N. on 5/17/2024

Monica G. on 5/30/2024

Jayshree D. on 6/15/2024

Glenn T. on 7/5/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6669 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7920 hours of CE.

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$59 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$79 per 1 year per user